Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential

Mitochondrial dysfunction is strongly implicated in the etiology of idiopathic and genetic Parkinson’s disease (PD). However, strategies aimed at ameliorating mitochondrial dysfunction, including antioxidants, antidiabetic drugs, and iron chelators, have failed in disease-modification clinical trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Henrich, Martin T., Oertel, Wolfgang H., Surmeier, D. James, Geibl, Fanni F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640762/
https://www.ncbi.nlm.nih.gov/pubmed/37951933
http://dx.doi.org/10.1186/s13024-023-00676-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640762/
https://www.ncbi.nlm.nih.gov/pubmed/37951933
http://dx.doi.org/10.1186/s13024-023-00676-7

Ejemplares similares